NBY News and Press, NovaBay Pharmaceuticals Inc. From 07/19/21

NovaBay Pharmaceuticals (NBY) has partnered with Harrow Health company (HROW) ImprimisRx to promote prescription Avenova.Avenova is an antimicrobial lid and lash solution for the management of numerous chronic eye conditions.ImprimisRx's president John Saharek called ...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova for the eye care market, announces it has partnered with ImprimisRx, one of the nation’s leading ophthalmology-focused pharmaceutical businesses, to pr...

Are These Penny Stocks on Your List For Next Week? With a new week upon us, the opportunity to find valuable penny stocks to watch is once again palpable. But, to do so, investors need to consider a few factors. For one, what is going on in the world right now, and how will it shape the...

7 Top Penny Stocks That Investors Are Watching in July 2021 Creating a penny stocks watchlist is one of the most crucial steps to investing in small caps. While many choose to find penny stocks on Reddit or other social media sites, using research and information to create a watchli...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova ® for the eye care market and CelleRx ® for the beauty market, announces that management will participate at the upcoming investment confere...

Self-diagnostic device designed to assist Avenova customers with management of common lid and lash problems NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focusing on expanding its presence in the eye and skin care market, announ...

NovaBay Pharmaceuticals, Inc. (NBY) Q1 2021 Earnings Conference Call May 06, 2021 04:30 PM ET Company Participants Jody Cain - Investor Relations-LHA Justin Hall - President and Chief Executive Officer Andy Jones - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg...

Over-the counter (“OTC”) Avenova ® revenue topped $1 million for the first time with record unit sales Cash and cash equivalents of $10.5 million as of March 31, 2021 Extending the Avenova product line with complementary products Conf...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces it will report financial results for the three months ended March 31, 2021 after market close on Thursday, May 6, 2021 and will hold an investment community conference call that day at 4:30 p.m. Eastern time. ...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova for the eye care market, announces the availability of its new Warm Eye Compress on Amazon.com and on Avenova.com . This new, reusable heated eye comp...